Some points from the announcement;
- Commencement of production towards supply of medicinal cannabis to at least 6,000 Australian patients (3,000 from Bundy Site, 3,000 using imported cannabis extract),
- This arrangement is ongoing commencing from Q2 2020,
- Commencement of high CBD dosage clinical trials potentially from Q3 2020. The Southport facility is licensed for production and supply of the clinical trial material.
Positive news overall.
- Forums
- ASX - By Stock
- EPN
- Ann: Production commenced to support 6000 Australian Patients
Ann: Production commenced to support 6000 Australian Patients, page-8
-
- There are more pages in this discussion • 43 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add EPN (ASX) to my watchlist
|
|||||
Last
2.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $7.208M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
EPN (ASX) Chart |
Day chart unavailable
The Watchlist
SER
STRATEGIC ENERGY RESOURCES LIMITED
David DeTata, Managing Director
David DeTata
Managing Director
SPONSORED BY The Market Online